Spots Global Cancer Trial Database for Tumor Response in Hypofractionated Radiotherapy

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Tumor Response in Hypofractionated Radiotherapy

Official Title: Biomarkers of Tumor Response in Hypofractionated Radiotherapy

Study ID: NCT02854449

Conditions

Neoplasms

Interventions

Study Description

Brief Summary: This study will follow-up different immune cell populations in the blood before, during and after high dose radiation therapy which should give new information of the efficacy of Local Hypofractionated Radiotherapy and a rationale for adjuvant immunotherapy.

Detailed Description: * Patient information and collection of a signed informed consent form * Clinical data collection * Blood samples of 5 mL: 1. after registration, prior to the first fraction of radiotherapy 2. during radiotherapy sessions 3. one month, 3 months after the last radiotherapy session * Storage of the blood samples at ambient temperature * Transportation of the samples to the Institute of Biology of Lille (IBL) - CNRS UMR8161 for analysis * Destruction of the samples at the end of the analysis